J Peter Cegielski

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Infect Dis Clin North Am 16:1-58. 2002
  2. pmc Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of origin
    Allison B Taylor
    Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, the US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e49355. 2012
  3. ncbi request reprint [Eliminating tuberculosis one neighborhood at a time]
    J Peter Cegielski
    Centros para el Control y la Prevención de Enfermedades, Atlanta, Georgia, Estados Unidos de América
    Rev Panam Salud Publica 34:284-94. 2013
  4. pmc Eliminating tuberculosis one neighborhood at a time
    J Peter Cegielski
    Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
    Am J Public Health 103:1292-300. 2013
  5. ncbi request reprint Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Epidemiol 176:409-22. 2012
  6. ncbi request reprint HIV infection and multidrug-resistant tuberculosis: the perfect storm
    Charles D Wells
    Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:S86-107. 2007
  7. doi request reprint Extensively drug-resistant tuberculosis in the United States, 1993-2007
    N Sarita Shah
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E 10, Atlanta, GA 30333, USA
    JAMA 300:2153-60. 2008
  8. ncbi request reprint Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009
    Ekaterina V Kurbatova
    Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 57:1081-93. 2013
  9. ncbi request reprint Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
    Ekaterina V Kurbatova
    U S Centers for Disease Control and Prevention, International Research and Programs Branch, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA
    Tuberculosis (Edinb) 92:397-403. 2012
  10. ncbi request reprint Mortality Among Tuberculosis Patients With Acquired Resistance to Second-line Antituberculosis Drugs-United States, 1993-2008
    Julia V Ershova
    Division of Tuberculosis Elimination, International Research and Programs Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 59:465-72. 2014

Detail Information

Publications14

  1. ncbi request reprint The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Infect Dis Clin North Am 16:1-58. 2002
    ..Still, recent developments in immunology, biochemistry, and molecular biology suggest that new knowledge and tools are just around the corner. These will enhance the ability to conquer this microbe by the end of the current century...
  2. pmc Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of origin
    Allison B Taylor
    Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, the US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 7:e49355. 2012
    ..Our objective was to determine whether the prevalence of drug resistance among foreign-born TB cases correlates better with data from the Global DRS or with data on foreign-born TB cases in the NTSS...
  3. ncbi request reprint [Eliminating tuberculosis one neighborhood at a time]
    J Peter Cegielski
    Centros para el Control y la Prevención de Enfermedades, Atlanta, Georgia, Estados Unidos de América
    Rev Panam Salud Publica 34:284-94. 2013
    ..We evaluated a strategy for preventing tuberculosis (TB) in communities most affected by it...
  4. pmc Eliminating tuberculosis one neighborhood at a time
    J Peter Cegielski
    Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
    Am J Public Health 103:1292-300. 2013
    ..We evaluated a strategy for preventing tuberculosis (TB) in communities most affected by it...
  5. ncbi request reprint Nutritional risk factors for tuberculosis among adults in the United States, 1971-1992
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Epidemiol 176:409-22. 2012
    ..A low serum albumin level also increased the risk of TB, but low vitamin A, thiamine, riboflavin, and iron status did not. A population's nutritional profile is an important determinant of its TB incidence...
  6. ncbi request reprint HIV infection and multidrug-resistant tuberculosis: the perfect storm
    Charles D Wells
    Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 196:S86-107. 2007
    ..The global human immunodeficiency virus (HIV) infection epidemic has caused explosive increases in TB incidence and may be contributing to increases in MDR-TB prevalence...
  7. doi request reprint Extensively drug-resistant tuberculosis in the United States, 1993-2007
    N Sarita Shah
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop E 10, Atlanta, GA 30333, USA
    JAMA 300:2153-60. 2008
    ..Worldwide emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised global public health concern, given the limited therapy options and high mortality...
  8. ncbi request reprint Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009
    Ekaterina V Kurbatova
    Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 57:1081-93. 2013
    ..Pyrazinamide (PZA) is essential in tuberculosis treatment. We describe the prevalence, trends, and predictors of PZA resistance in Mycobacterium tuberculosis complex (MTBC) in the United States...
  9. ncbi request reprint Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects
    Ekaterina V Kurbatova
    U S Centers for Disease Control and Prevention, International Research and Programs Branch, Division of Tuberculosis Elimination, Atlanta, GA 30333, USA
    Tuberculosis (Edinb) 92:397-403. 2012
    ..To prevent treatment default, management of patients who are unemployed, homeless, alcoholic, or have a prison history requires extra measures to insure treatment completion...
  10. ncbi request reprint Mortality Among Tuberculosis Patients With Acquired Resistance to Second-line Antituberculosis Drugs-United States, 1993-2008
    Julia V Ershova
    Division of Tuberculosis Elimination, International Research and Programs Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 59:465-72. 2014
    ....
  11. doi request reprint Acquired resistance to second-line drugs among persons with tuberculosis in the United States
    Julia V Ershova
    US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 55:1600-7. 2012
    ..The objectives of this study were to identify risk factors for acquired resistance (AR) to injectable SLDs (INJ SLDs) and fluoroquinolones in the US National tuberculosis Surveillance System, 1993-2008...
  12. pmc Worldwide emergence of extensively drug-resistant tuberculosis
    N Sarita Shah
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 13:380-7. 2007
    ..9%) met criteria for XDR TB. Further investigation of population-based trends and expanded efforts to prevent drug resistance and effectively treat patients with MDR TB are crucial for protection of public health and control of TB...
  13. doi request reprint Extensively drug-resistant tuberculosis: "there must be some kind of way out of here"
    J Peter Cegielski
    Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 50:S195-200. 2010
    ....
  14. pmc Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance
    Courtney M Yuen
    Division of Tuberculosis Elimination, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, U S Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 8:e83006. 2013
    ..acquired resistance) can lead to emergence of resistant strains and consequent poor clinical outcomes. However, it is unknown whether Mycobacterium tuberculosis complex species and lineage affects the likelihood of acquired resistance...